Morning Briefing
Summaries of health policy coverage from major news organizations
Scientists 'Tinker' With HIV Drug Chemistry Hoping To Reduce Costs
The Clinton Health Access Initiative, founded by former President Bill Clinton, with funding from the Bill & Melinda Gates Foundation and the U.K. government, has hired former pharmaceutical company scientists "to tinker with the chemistry used to synthesize a key [HIV] drug, tenofovir, reducing the cost of manufacturing," the Wall Street Journal reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
